December 19, 2023
The 2024 Large Employer Health Care Strategy Survey found that among the 152 large employers participating in the survey, cancer remains at the top of the list of cost drivers of health care costs. This is partially due to an increase in late-stage cancers as a result of pandemic-driven delays in medical care and the rapid pace of clinical innovation introducing more effective, but costly, therapies to an already complex treatment landscape.
Higher Prevalence of Late-stage Cancers Due to Delayed Screenings
Recommendations to Improve Quality and Reduce Costs
Consider how Centers of Excellence (COEs) can enhance treatment outcomes and patient experience for patients in need of more novel and complex therapies.
53%
of employers will
have COEs in place
for cancer in 2024
Consider alternative payment models to reward better outcomes.
Work with your partners to ensure ease of access to quality care and innovative treatments by building a comprehensive cancer management program that provides navigation, second-opinion and decision-support services.
Consider the impact of innovation in precision medicine and new screenings for cancer care and detection.
31%
of employers will
cover genomic
testing for cancer
treatments in 2024
Cultivate a workplace culture, including accommodations, that supports cancer as a chronic condition and prioritizes affordability for patients and caregivers.
11%
of employers will
cover multi-cancer
early detection
blood tests in 2024
Evaluate prior authorization to remove barriers and promote access to most effective treatments.
For more information on these recommendations, please read Emerging Trends in Cancer Care.
You can view the infographic by clicking the download button below.
Cancer: Improve Quality, Reduce Costs
Download
More Topics
Resource
Plan Design & Administration
Pharmacy
Pharmacy/Prescription Drugs